-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MY7RLtKdil82HSOnPGYvrGC1nbi5kVRIMcNm40MinEgxbQElO8/aKIIg5wROvBl6 EB3U3X0eiUEkigCmnnAskw== 0001076998-06-000001.txt : 20060418 0001076998-06-000001.hdr.sgml : 20060418 20060418155813 ACCESSION NUMBER: 0001076998-06-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060414 FILED AS OF DATE: 20060418 DATE AS OF CHANGE: 20060418 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUNY PARK SCIENCE III STREET 2: SUITE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 BUSINESS PHONE: 6077772775 MAIL ADDRESS: STREET 1: SUNYPARK SCIENCE III STREET 2: STE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAUST JOHN G PH D CENTRAL INDEX KEY: 0001076998 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18170 FILM NUMBER: 06764851 BUSINESS ADDRESS: BUSINESS PHONE: 3014177070 MAIL ADDRESS: STREET 1: CRYOMEDICAL SCIENCES INC STREET 2: 1300 PICCARD DRIVE STE 102 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-04-14 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001076998 BAUST JOHN G PH D C/O BIOLIFE SOLUTIONS, INC. 171 FRONT STREET OWEGO NY 13827 1 1 0 0 CEO Common Stock 2006-04-14 4 M 0 10000 .04 A 3600681 D Common Stock 2006-04-14 4 M 0 432000 .04 A 3600681 D Common Stock 2006-04-14 4 M 0 100000 .04 A 3600681 D Common Stock 2006-04-14 4 M 0 800000 .04 A 3600681 D Common Stock 2006-04-14 4 M 0 600000 .04 A 3600681 D Common Stock 2006-04-14 4 X 0 664063 .04 A 3600681 D Common Stock 2006-04-14 4 X 0 326555 .04 A 3600681 D Common Stock 2006-04-14 4 C 0 664063 .08 A 3600681 D Stock Option (right to buy) .04 2006-04-14 4 M 0 10000 D 2000-03-05 2007-03-05 Common Stock 10000 1600000 D Stock Option (right to buy) .04 2006-04-14 4 M 0 432000 D 1999-08-31 2008-08-31 Common Stock 432000 1600000 D Stock Option (right to buy) .04 2006-04-14 4 M 0 100000 D 2000-01-03 2010-01-03 Common Stock 100000 1600000 D Stock Option (right to buy) .04 2006-04-14 4 M 0 800000 D 2005-08-07 2011-08-07 Common Stock 800000 1600000 D Stock Option (right to buy) .04 2006-04-14 4 M 0 600000 D 2006-07-01 2012-07-01 Common Stock 600000 1600000 D Warrant (right to buy) .04 2006-04-14 4 X 0 664063 D 2003-12-18 2013-12-18 Common Stock 664063 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 326555 D 2003-08-01 2008-08-01 Common Stock 326555 0 D Series G Convertible Preferred Stock 2006-04-14 4 C 0 2.125 D Common Stock 664063 0 D In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 through 4/14/2006 at $.04 per share. The consideration paid consisted of $90,000 in the form of forgiveness of accrued vacation pay, unreimbursed auto allowance and cash expenditures on behalf of the Company, $10,000 in cash, and $17,035 to be paid at the rate of $1,000 per month. The exercise price of the option was $2.50 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 through 4/14/2006 at $.04 per share. The exercise price of the optoin was $1.25 per share In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 through 4/14/2006 at $.04 per share. The exercise price of the option was $1.25 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 through 4/14/2006 at $.04 per share. The exercise price of the option was $.25 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 through 4/14/2006 at $.04 per share. The exercise price of the option was $.25 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 through 4/14/2006 at $.04 per share. The exercise price of the warrant was $.08 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 through 4/14/2006 at $.04 per share. The exercise price of the warrant was $.08 per share. The Series G Convertible Preferred Stock was convertible into 312,500 shares of common stock at anytime, and had no expiration date. John G. Baust 2006-04-14 -----END PRIVACY-ENHANCED MESSAGE-----